New York University Langone Health — New York, New York

New York University Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

New York University Langone Health has participated in 45 clinical trials with 23 currently active.

Therapeutic areas: Amyloid Cardiomyopathy, Transthyretin-Related, Neovascular Age-related Macular Degeneration, Prostate Cancer.

Sponsors: Eidos Therapeutics, a BridgeBio company, Jaeb Center for Health Research, BioProtect.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Langone Health?

New York University Langone Health has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Langone Health conducted?

New York University Langone Health has 45 clinical trials on record, with 23 currently active. Their work covers Amyloid Cardiomyopathy, Transthyretin-Related, Neovascular Age-related Macular Degeneration, Prostate Cancer.

Is New York University Langone Health accredited by Crixeo Health?

Yes — New York University Langone Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.